ClinicalThought

Share

Program Content

Activities

  • ADCs Targeting CEACAM5 in NSCLC
    The Potential of Antibody‒Drug Conjugates Targeting CEACAM5 in NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 30, 2023

Faculty

cover img faculity

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Paris-Saclay University
International Center for Thoracic Cancers
Villejuif, France

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi